Jigar Amin Email

Director Medical Affairs and Global External Engagement . Hemab Therapeutics

Current Roles

Employees:
51
Revenue:
$7.9M
About
Hemab ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
Hemab Therapeutics Address
125 Cambridge Park Drive
Copenhagen, null
Hemab Therapeutics Email

Past Companies

Hemab TherapeuticsDirector of Medical Affairs and Global External Engagement
Alnylam PharmaceuticalsMedical Science Liaison, Rare Disease
Novo NordiskSenior Hemophilia Medical Liaison

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.